SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-078840
Filing Date
2022-12-12
Accepted
2022-12-09 17:57:30
Documents
12
Period of Report
2022-12-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea169928-8k_emmauslife.htm   iXBRL 8-K 37788
  Complete submission text file 0001213900-22-078840.txt   205644

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE emma-20221208.xsd EX-101.SCH 3221
3 XBRL LABEL FILE emma-20221208_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE emma-20221208_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT ea169928-8k_emmauslife_htm.xml XML 3291
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 221455794
SIC: 2834 Pharmaceutical Preparations